As of close of business last night, Cara Therapeutics Inc’s stock clocked out at $0.71, down -0.14% from its previous closing price of $0.71. On the day, 601451 shares were traded.
Ratios:
To gain a deeper understanding of CARA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.43 and its Current Ratio is at 4.54. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on March 08, 2023, Downgraded its rating to Underperform and sets its target price to $6 from $13 previously.
On March 08, 2022, JP Morgan Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $17 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 05 ’24 when Terrillion Scott sold 2,753 shares for $0.83 per share. The transaction valued at 2,285 led to the insider holds 88,247 shares of the business.
Goncalves Joana sold 2,753 shares of CARA for $2,285 on Apr 05 ’24. The CHIEF MEDICAL OFFICER now owns 53,365 shares after completing the transaction at $0.83 per share. On Feb 29 ’24, another insider, Posner Christopher, who serves as the PRESIDENT AND CEO of the company, sold 5,834 shares for $0.89 each. As a result, the insider received 5,192 and left with 180,521 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.85 while its Price-to-Book (P/B) ratio in mrq is 0.68.
Stock Price History:
Over the past 52 weeks, CARA has reached a high of $4.67, while it has fallen to a 52-week low of $0.50.
Shares Statistics:
A total of 54.48M shares are outstanding, with a floating share count of 46.46M. Insiders hold about 15.00% of the company’s shares, while institutions hold 46.61% stake in the company.
Earnings Estimates
As of right now, Marathon Digital Holdings, Inc. analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $10.43, with high estimates of $27.19 and low estimates of $62.86.
Analysts are recommending an EPS of between $Energy and $Consumer Cyclical for the fiscal current year, implying an average EPS of $Communication Services.
